thymoquinone has been researched along with Angiogenesis, Pathologic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, N; Chen, S; Fang, M; Hu, Z; Hussien, AB; Lou, C; Wang, Y; Wu, F; Wu, J; Ye, S | 1 |
| Ahmad, FJ; Ahmad, I; Akhter, S; Alam Rizvi, MM; Hafeez, Z; Jain, GK; Zafar, S | 1 |
| Azab, B; Das, S; Das, SK; Emdad, L; Fisher, PB; Kumar, BN; Mandal, M; Rajput, S; Santhekadur, PK; Sarkar, D; Sarkar, S | 1 |
| Jiang, H; Li, S; Liu, L; Ma, Y; Pan, H; Pan, S; Wang, D; Wang, J; Wu, Y; Xu, D; Zhang, Y; Zhao, B | 1 |
| Aruoma, OI; Chun, KS; Kundu, J; Kundu, JK | 1 |
| Kang, J; Kong, L; Ren, Y; Su, X; Yu, N | 1 |
| Aggarwal, BB; Cho, SG; Liu, M; Pang, X; Rodriguez, M; Sethi, G; Wang, Y; Yi, T; Yi, Z | 1 |
| Aggarwal, BB; Nair, HB; Prasad, S; Ravindran, J; Sung, B; Tekmal, RR | 1 |
| Glass, J; Jafri, SH; Kleiner-Hancock, H; Prince, M; Shi, R; Zhang, S | 1 |
| Chen, QY; Cheng, SW; Liao, W; Lin, ZQ; Liu, A; Liu, HX; Peng, L; Shen, WD; Shen, Y; Xu, HZ; Yang, SZ; Ying, XZ | 1 |
1 review(s) available for thymoquinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Mechanistic perspectives on cancer chemoprevention/chemotherapeutic effects of thymoquinone.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Transformation, Neoplastic; Humans; Neoplasms; Neovascularization, Pathologic; Nigella sativa; Seeds; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
9 other study(ies) available for thymoquinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Thymoquinone has a synergistic effect with PHD inhibitors to ameliorate ischemic brain damage in mice.
Topics: Animals; Benzoquinones; Brain; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemic Stroke; Male; Mice; Neovascularization, Pathologic; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Stroke; Vascular Endothelial Growth Factor A | 2022 |
Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Female; Humans; Lipids; MCF-7 Cells; Nanocapsules; Neovascularization, Pathologic; Rats; Structure-Activity Relationship | 2020 |
Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; Benzoquinones; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Tamoxifen; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2013 |
Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Down-Regulation; Drug Resistance, Neoplasm; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Random Allocation; Xenograft Model Antitumor Assays | 2014 |
Thymoquinone inhibits inflammation, neoangiogenesis and vascular remodeling in asthma mice.
Topics: Airway Remodeling; Animals; Asthma; Benzoquinones; Disease Models, Animal; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Interleukin-4; Interleukin-5; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Nerve Tissue Proteins; Nigella sativa; Oncogene Protein v-akt; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways.
Topics: Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Male; MAP Kinase Signaling System; Mice; Mice, SCID; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2008 |
Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential.
Topics: Anti-Inflammatory Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Humans; Lactic Acid; Nanoparticles; Neoplasm Metastasis; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2010 |
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lipopolysaccharides; Lung Neoplasms; Maximum Tolerated Dose; Mice; Mice, SCID; Mice, Transgenic; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Topics: Animals; Antigens, CD34; Antineoplastic Agents; Apoptosis; Benzoquinones; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; NF-kappa B; Oligopeptides; Osteosarcoma; Signal Transduction; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2013 |